Purchase Order 75N95A25P00065
Award Date
6/17/25
Potential Completion Date
6/16/26
Potential Value
$4.1K
Federal Agency
National Institute of Neurological Disorders and Stroke
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Exton, PA 19341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Pharmaron, Inc. for $24,624.00. The contract is to obtain pharmacokinetic exposure data from mouse PK studies and plasma protein binding assays, which are common preclinical services provided by Pharmaron, a global contract research organization (CRO) specializing in drug discovery and development. This contract...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, awarded a Firm Fixed Price Purchase Order contract to Pharmaron (Exton) Lab Services LLC, doing business as Absorption Systems, to conduct an in-vivo pharmacokinetic (PK) study to obtain preliminary PK data to justify in vivo experiments for an HIV antisense oligonucleotide (ASO) project. The contract, valued at $15,600.00, has a completion date of November 24, 2025 and was not set aside for any particular...
This firm-fixed-price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services (HHS), to Pharmaron (Exton) Lab Services LLC, doing business as Absorption Systems. The $146,630 contract is for the characterization of the sponsor's test articles via metabolic stability, CYP phenotyping, and in vitro metabolism studies. The contract has no set-aside designation and the work is to be completed by March...
This is a firm fixed-price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Pharmaron, Inc. for $149,520.00. The award is under the NIH Bioanalysis Testing Services 2015-2020 indefinite delivery/indefinite quantity (IDIQ) contract vehicle. Pharmaron, a minority-owned, for-profit contract research organization (CRO), will provide pharmacokinetics assessments, toxicity studies, and ion channel testing...
This federal contract award is to Pharmaron, Inc., a global contract research organization (CRO) that provides preclinical research services for pharmaceutical and biotechnology companies, as well as government agencies. The contract, valued at $24,900, is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH). The award does not have a set-aside designation. Pharmaron, which is classified as a...
This is a federal contract award to Pharmaron, Inc., a global contract research organization (CRO) specializing in preclinical research services for the pharmaceutical and biotechnology industries, as well as government agencies. The contract was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), and is part of the NIH Bioanalysis Testing Services 2015-2020 master indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract...
This firm fixed-price purchase order contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart, Lung, and Blood Institute to Pharmaron, Inc., a minority-owned for-profit contract research organization, to conduct Good Laboratory Practice (GLP) toxicity studies in rats and dogs. The $102,250.00 contract supports the Institute's Investigational New Drug (IND) enablement project, with Pharmaron performing services such as...
This firm fixed-price purchase order contract, valued at $54,000.00, was awarded by the National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health (NIH), to Pharmaron, Inc. Pharmaron is a minority-owned, for-profit Subcontinent Asian (Asian-Indian) American contract research organization that specializes in preclinical drug discovery and development services. The contract is for testing 20 small molecule compounds in rat pharmacokinetic...
The Department of Health and Human Services National Center for Advancing Translational Sciences awarded a $19,504 firm-fixed-price purchase order to Pharmaron (Exton) Lab Services LLC, doing business as Absorption Systems, to determine the pharmacokinetics in rats and dogs and conduct in vitro transporter studies for a novel drug compound. Absorption Systems is a global life science contract research organization that has provided testing services related to COVID-19 treatments and conducted...
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), to Pharmaron, Inc. The $143,550.00 firm fixed-price delivery order falls under the NIH Bioanalysis Testing Services 2015-2020 contract vehicle, which provides preclinical research services to support drug discovery and development. The contract does not have a set-aside designation. Pharmaron, a minority-owned, for-profit organization...